Latest news with #HealthcareServices
ABC News
12-07-2025
- Health
- ABC News
Christine Yerbury would like to move somewhere without stairs
Christine Yerbury has been waiting since October to receive an occupational therapy assessment to allow her to receive a Deaf-appropriate device.
Yahoo
29-06-2025
- Business
- Yahoo
5 Insightful Analyst Questions From Owens & Minor's Q1 Earnings Call
Owens & Minor experienced a challenging start to 2025, as market reaction turned negative following flat revenue and a miss versus Wall Street's top-line expectations. Management attributed the subdued results largely to external pressures, especially tariffs and adverse currency movements, which impacted the Products and Healthcare Services segment. CEO Edward Pesicka highlighted, 'We can no longer absorb these costs,' referencing the significant tariff increases on imported medical products. Meanwhile, the Patient Direct segment posted notable growth, driven by increased investments in sleep therapy and sales resources, but this was not enough to offset broader headwinds. Is now the time to buy OMI? Find out in our full research report (it's free). Revenue: $2.63 billion vs analyst estimates of $2.67 billion (flat year on year, 1.6% miss) Adjusted EPS: $0.23 vs analyst estimates of $0.20 (14.5% beat) Adjusted EBITDA: $121.9 million vs analyst estimates of $116.7 million (4.6% margin, 4.4% beat) The company reconfirmed its revenue guidance for the full year of $11 billion at the midpoint Management reiterated its full-year Adjusted EPS guidance of $1.73 at the midpoint EBITDA guidance for the full year is $575 million at the midpoint, in line with analyst expectations Operating Margin: 0%, in line with the same quarter last year Market Capitalization: $638.2 million While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention. John Stansel (JPMorgan) asked how customers are responding to tariff-related price increases. CEO Edward Pesicka explained that while the company is working to find alternative products for customers, they must pass on tariff costs due to low margins and cannot sell at a loss. Michael Cherny (Leerink Partners, via Ahmed) requested clarification on the $100–$150 million tariff exposure and its treatment in guidance. Pesicka confirmed this exposure is largely in the Products and Healthcare Services segment and will be passed through via price increases. Kevin Caliendo (UBS) inquired about the impact of Rotech acquisition financing and its effect on interest expense guidance. CFO Jonathan Leon noted that interest costs will be updated once the deal closes, and that current guidance does not yet reflect these changes. Eric Coldwell (Baird) questioned how the timing of tariff implementation and price increases aligns, and what happens if customers reject price hikes. Pesicka stated price increases are timed with inventory turnover and that the company cannot absorb tariffs, so alternatives or loss of sales may result. Eric Coldwell (Baird) also asked whether Rotech's performance still aligns with acquisition expectations. Leon confirmed Rotech's results are in line with the deal model, with anticipated accretion in the second year. Looking ahead, our team will monitor (1) the effectiveness and customer acceptance of tariff-driven price increases, (2) the performance and integration of the Patient Direct segment as new therapies and revenue cycle initiatives scale, and (3) developments regarding the potential sale of the Products and Healthcare Services segment and the finalization of the Rotech acquisition. Execution on these fronts will be critical in shaping Owens & Minor's business trajectory and financial health. Owens & Minor currently trades at $7.96, up from $7.73 just before the earnings. Is the company at an inflection point that warrants a buy or sell? See for yourself in our full research report (it's free). The market surged in 2024 and reached record highs after Donald Trump's presidential victory in November, but questions about new economic policies are adding much uncertainty for 2025. While the crowd speculates what might happen next, we're homing in on the companies that can succeed regardless of the political or macroeconomic environment. Put yourself in the driver's seat and build a durable portfolio by checking out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025). Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
05-06-2025
- Business
- Yahoo
Is Healthcare Services Group (HCSG) Outperforming Other Business Services Stocks This Year?
Investors interested in Business Services stocks should always be looking to find the best-performing companies in the group. Is Healthcare Services (HCSG) one of those stocks right now? Let's take a closer look at the stock's year-to-date performance to find out. Healthcare Services is a member of the Business Services sector. This group includes 271 individual stocks and currently holds a Zacks Sector Rank of #3. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst. The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. Healthcare Services is currently sporting a Zacks Rank of #1 (Strong Buy). Within the past quarter, the Zacks Consensus Estimate for HCSG's full-year earnings has moved 13.5% higher. This shows that analyst sentiment has improved and the company's earnings outlook is stronger. Our latest available data shows that HCSG has returned about 22.7% since the start of the calendar year. Meanwhile, the Business Services sector has returned an average of -0.3% on a year-to-date basis. This means that Healthcare Services is outperforming the sector as a whole this year. Loop Industries, Inc. (LOOP) is another Business Services stock that has outperformed the sector so far this year. Since the beginning of the year, the stock has returned 30.8%. In Loop Industries, Inc.'s case, the consensus EPS estimate for the current year increased 2.2% over the past three months. The stock currently has a Zacks Rank #1 (Strong Buy). To break things down more, Healthcare Services belongs to the Business - Services industry, a group that includes 26 individual companies and currently sits at #32 in the Zacks Industry Rank. On average, this group has gained an average of 18.3% so far this year, meaning that HCSG is performing better in terms of year-to-date returns. On the other hand, Loop Industries, Inc. belongs to the Technology Services industry. This 130-stock industry is currently ranked #51. The industry has moved +7.5% year to date. Investors with an interest in Business Services stocks should continue to track Healthcare Services and Loop Industries, Inc. These stocks will be looking to continue their solid performance. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Healthcare Services Group, Inc. (HCSG) : Free Stock Analysis Report Loop Industries, Inc. (LOOP) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research
Yahoo
21-05-2025
- Business
- Yahoo
Can Healthcare Services (HCSG) Run Higher on Rising Earnings Estimates?
Healthcare Services (HCSG) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might continue with analysts still raising their earnings estimates for the company. Analysts' growing optimism on the earnings prospects of this provider of housekeeping, laundry and dietary services to health care facilities is driving estimates higher, which should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. This insight is at the core of our stock rating tool -- the Zacks Rank. The five-grade Zacks Rank system, which ranges from a Zacks Rank #1 (Strong Buy) to a Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record of outperformance, with Zacks #1 Ranked stocks generating an average annual return of +25% since 2008. For Healthcare Services, there has been strong agreement among the covering analysts in raising earnings estimates, which has helped push consensus estimates considerably higher for the next quarter and full year. The chart below shows the evolution of forward 12-month Zacks Consensus EPS estimate: The company is expected to earn $0.20 per share for the current quarter, which represents a year-over-year change of 0%. The Zacks Consensus Estimate for Healthcare Services has increased 5.26% over the last 30 days, as one estimate has gone higher compared to no negative revisions. The company is expected to earn $0.84 per share for the full year, which represents a change of +58.49% from the prior-year number. There has been an encouraging trend in estimate revisions for the current year as well. Over the past month, one estimate has moved up for Healthcare Services versus no negative revisions. This has pushed the consensus estimate 5% higher. The promising estimate revisions have helped Healthcare Services earn a Zacks Rank #1 (Strong Buy). The Zacks Rank is a tried-and-tested rating tool that helps investors effectively harness the power of earnings estimate revisions and make the right investment decision. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Our research shows that stocks with Zacks Rank #1 (Strong Buy) and 2 (Buy) significantly outperform the S&P 500. Healthcare Services shares have added 57.1% over the past four weeks, suggesting that investors are betting on its impressive estimate revisions. So, you may consider adding it to your portfolio right away to benefit from its earnings growth prospects. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Healthcare Services Group, Inc. (HCSG) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research
Yahoo
20-05-2025
- Business
- Yahoo
Is GDS Holdings (GDS) Outperforming Other Business Services Stocks This Year?
For those looking to find strong Business Services stocks, it is prudent to search for companies in the group that are outperforming their peers. Is GDS Holdings (GDS) one of those stocks right now? A quick glance at the company's year-to-date performance in comparison to the rest of the Business Services sector should help us answer this question. GDS Holdings is one of 270 individual stocks in the Business Services sector. Collectively, these companies sit at #3 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group. The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. GDS Holdings is currently sporting a Zacks Rank of #2 (Buy). Within the past quarter, the Zacks Consensus Estimate for GDS' full-year earnings has moved 10.7% higher. This shows that analyst sentiment has improved and the company's earnings outlook is stronger. According to our latest data, GDS has moved about 14% on a year-to-date basis. Meanwhile, the Business Services sector has returned an average of 5.2% on a year-to-date basis. This shows that GDS Holdings is outperforming its peers so far this year. Healthcare Services (HCSG) is another Business Services stock that has outperformed the sector so far this year. Since the beginning of the year, the stock has returned 26.3%. The consensus estimate for Healthcare Services' current year EPS has increased 8.1% over the past three months. The stock currently has a Zacks Rank #2 (Buy). Breaking things down more, GDS Holdings is a member of the Technology Services industry, which includes 129 individual companies and currently sits at #48 in the Zacks Industry Rank. On average, this group has gained an average of 5.1% so far this year, meaning that GDS is performing better in terms of year-to-date returns. In contrast, Healthcare Services falls under the Business - Services industry. Currently, this industry has 26 stocks and is ranked #40. Since the beginning of the year, the industry has moved +17.1%. GDS Holdings and Healthcare Services could continue their solid performance, so investors interested in Business Services stocks should continue to pay close attention to these stocks. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report GDS Holdings (GDS) : Free Stock Analysis Report Healthcare Services Group, Inc. (HCSG) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
